Philips’ Trilogy offer multiple ventilation modes, real time data sharing capabilities and a long battery life that allows patients to have a near normal quality of life.
SANTA CLARA, California, Sept. 13, 2017 /PRNewswire/ — Based on its recent analysis of the home ventilation market, Frost & Sullivan recognizes Philips with the 2017 North American Home Ventilation Product Leadership Award for its Trilogy series of home care ventilators. Trilogy ventilators are cost-effective, invasive and non-invasive, with multi-mode capabilities providing easy-to-view and -share data for near-real-time patient care.
According to the Center for Disease Control and Prevention (CDC), chronic lower respiratory disease is the third-leading cause of death in the United States. The prevalence of respiratory disease creates pressure on care providers and vendors to create population health management solutions to replace existing episodic care protocols. With reimbursements shifting away from traditional fee-for-service models to value-based care, hospitals are increasingly required to demonstrate improvements in care provision to qualify for reimbursements, including faster discharge rates, lower inpatient bed days, lower readmission rates, and better follow-up care and post-treatment management. To address these issues, ventilator manufacturers need to look at a combination of products and solutions to appeal to patients with chronic diseases, both at home and in sub-acute facilities. To help prevent hospitalization, the best ventilation products will be able to share ventilation data seamlessly with care providers.
Philips offers the Trilogy 100 and Trilogy 200 ventilators as part of its extensive sleep and respiratory care solutions. Both of these products are compact, portable, and have multiple circuit choices to help clinicians caring for patients with different chronic respiratory conditions and ventilation requirements.
“It’s worth noting that, in the United States, clinicians are using Trilogy 100 and Trilogy 200 ventilator units to treat hundreds of thousands of patients with different respiratory conditions,” said Senior Research Analyst, Tanvir Jaikishen. “Philips’ extensive experience in IT really strengthens and distinguishes it from competitors in the home ventilation space.”
Philips’ Trilogy products have a number of standout features:
- Digital Auto-Trak, available on both the Trilogy 100 and Trilogy 200, is an algorithm that can detect inspiration and expiration to react and respond to every breath, with a Sensitive Auto-Trak setting for an enhanced triggering response for patients all while compensating for leak.
- DirectView reporting software stores and analyzes data and streamline reporting to allow care providers to make adjustments using different ventilation modes as required.
- Care Orchestrator, a patient management application, delivers data wirelessly from Bluetooth-enabled Trilogy devices directly to the tablets, mobile devices or desktops of care providers multiple times per day, enabling early intervention if needed.
- The Trilogy 100 and Trilogy 200 ventilators display pressure and flow graphically in a waveform format using the Waveform screen. This format enables fast synchronization between the patient and the ventilator, thus allowing for an expeditious transfer from the hospital to a sub-acute or home care setting.
“Philips’ Trilogy ventilation products provide hospitals with improvements in care provision, including faster discharge rates, lower inpatient bed days, lower readmission rates, and better follow-up care and post-treatment management,” said Jaikishen. “This really helps hospitals to better adapt to the emergence of quality-based care payment models in the healthcare industry.”
The Trilogy Series ventilators allow for ease of viewing patient data, the ability to quickly and easily share data, and data analytics on large patient data sets. Philips is a pioneer in the IT and analytics industry and these products’ interplay between data management and patient management is why Frost & Sullivan is recognizing Philip with the 2017 Award for North American Home Ventilation Product Leadership.
Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality, gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 70,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion.